Canagliflozin Extends Lifespan in Genetically Heterogeneous Male But Not Female Mice
2020
Canagliflozin (Cana) is an inhibitor of the sodium glucose transporter 2 (SGLT2), and is thought to act by blocking renal reuptake and intestinal absorption of glucose. Cana is FDA-approved for treatment of diabetes, and affords protection from cardiovascular and kidney diseases. In the context of the mouse Interventions Testing Program, genetically heterogeneous mice were given chow containing 180 ppm Cana at 7 months of age until their death. Cana extended median survival of male mice by 14%, with p
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
2
Citations
NaN
KQI